Page 103 - Sohini Das

Pharma industry considering 'ethics inspectors' to ensure better compliance

Pharma players to meet DoP to discuss suggestions around implementing ethical marketing practices code

Reliance Jio EBIT jumps 60% in Q3, operating revenue rises 28.3%

Jio's subscriber base as on December 31 was 370 million, which shows a 32.1 per cent YoY growth

Piramal sells healthcare analytics subsidiary DRG to Clarivate for $950 mn

The company said it was a strategic investment for PEL and it decided to sell as it saw good value for its shareholders. The sale value is roughly five times the annual sales of DRG

Wockhardt becomes first Indian company to get nod for novel antibiotics

While multinational companies have launched new antibiotics in India, there have been no new launches in the past 15 years in this category

Voot follows money on the OTT, but can it match the giants in the game?

Viacom 18 bets on reality shows and regional content as it switches over to a paid viewership model

Broadcasters plan to move court against TRAI's new cap on channel pricing

Broadcasters may not come out with channel pricing next week

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

Cipla, Glenmark get NPPA nod for inhaler pricing over 'innovative' quotient

Glenmark had appealed to the pricing regulator in 2016 asking for a differential price for its Digihaler

Sweet shake-up: Price relief for diabetes patients as drugs go off patent

The Rs 14,000-crore diabetes drug market in the country is witnessing a churn

Apex broadcasters' body decries Trai's new cap on channel pricing

IBF says it may consider legal options against amendments made to February 2019 order

More pay channels may become free-to-air after Trai's tariff amendments

Trai's amendment has forced broadcasters to go back to the drawing board as they revise pricing for channels

Centre may cap trade margins for drugs in stages; companies oppose plans

While the trade margins for branded generics are standardised by trade, the margins vary in the case of unbranded generics

Show off the year: Marvel to Uri, movies that moved India in 2019

Avengers: Endgame broke all records to sell over 8.6 mn tickets on BookMyShow, making it the highest-selling Hollywood movie

Year in review: In 2019, Indian pharma battled regulatory scare, and won

On the whole, rating agency ICRA maintained a stable outlook on the Indian pharmaceutical industry

Zee picks a cue from its viewership gains, raises bet on regional channels

Almost 15 channels of the 59 within its overall network are regional-language channels, with plans to fill key gaps in the future

JBL to Too Yumm, brands break into ad-free Amazon Prime viewing experience

Only the premium subscription-led service promises an ad-free experience.

NITI Aayog plans to bring all medical devices under one regulatory regime

The NITI Aayog has proposed to do away with the need to have manufacturing licences to register a medical device

Cipla plans to partner Ayushman Bharat; start dialogue with insurance firms

There is a plan to identify a list of essential medicines, including antibiotics, painkillers, etc, which the company may supply to the Ayushman Bharat-empanelled hospitals.

Jio redux: Reliance's entry into diagnostics industry may lower prices

With bigger players making inroads, share of organised sector to increase in a fragmented market

PharmEasy, 1mg, Netmeds look to power their brands, build trust in business

According to many reports, e-pharmacies have spent well over their capacities in building their brands